Terminated PHASE2 INTERVENTIONAL 1-arm NCT01980199

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Phase II Proof of Concept Trial to Determine Efficacy of Fexinidazole in Visceral Leishmaniasis Patients in Sudan

Sponsor: Drugs for Neglected Diseases

Updated 5 times since 2017 Last updated: Oct 29, 2015 Started: Nov 30, 2013 Primary completion: Nov 30, 2014 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of efficacy

Other terminated trials from Drugs for Neglected Diseases

See all terminations from Drugs for Neglected Diseases

Other Visceral Leishmaniasis trials with similar outcome

NCT01310738 · Phase PHASE4 · Feb 2015

Browse all Visceral Leishmaniasis trials

A PHASE2 clinical study on Visceral Leishmaniasis, this trial is terminated or withdrawn. The trial is conducted by Drugs for Neglected Diseases and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Drugs for Neglected Diseases

Data source: Drugs for Neglected Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Doka, Sudan